Background and aims Meta-analyses of randomized control trials investigating the
association between incident diabetes and statin use showed an increased risk of new …

Background. Current evidence indicates that statins increase the risk of new onset diabetes
mellitus (NOD) and also deteriorate the glycemic control in patients with known diabetes …

Abstract Background Diabetes Mellitus (DM) has become the third chronic non-
communicable disease that hits patients after tumors, cardiovascular and cerebrovascular …

Purpose: Many studies have proposed predictive models for type 2 diabetes mellitus
(T2DM). However, these predictive models have several limitations, such as user …

An extensive evaluation of disease occurrence after statin use based on a “hypothesis-free”
approach remains scarce. To examine the effect of statin use on the potential risk of …

Recently, meta‐analysis studies reported that hyperuricaemia is associated with higher
incidence of type 2 diabetes mellitus (T2DM), however, there are limited data on the Asian …

Although concern regarding the increased risk for new-onset diabetes mellitus (NODM) after
statin treatment has been raised, there has been a lack of evidence in real-world clinical …

Metabolic syndrome (MetS) is a complicated health problem that encompasses a variety of
metabolic disorders. In this study, we analyzed the relationship between the major …

There have been several reports showing that the statin use is associated with new-onset
diabetes mellitus (DM). The aim of the present study was to evaluate the impact of chronic …

Background: Statins have long been prescribed for the primary and secondary prevention of
cardiovascular disease (CVD) and kidney disease. Their benefits and efficacy are widely …